-
Je něco špatně v tomto záznamu ?
Antistaphylococcal Activities and ADME-Related Properties of Chlorinated Arylcarbamoylnaphthalenylcarbamates
T. Gonec, D. Pindjakova, L. Vrablova, T. Strharsky, H. Michnova, T. Kauerova, P. Kollar, M. Oravec, I. Jendrzejewska, A. Cizek, J. Jampilek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
APVV-17-0373
Slovak Research and Development Agency
UK/289/2022
Comenius University
UK/320/2022
Comenius University
LM2018123
Large Research Infrastructure CzeCOS
CZ.02.1.01/0.0/0.0/16_019/0000797
SustES-Adaptation strategies for sustainable ecosystem services and food security under ad-verse environmental conditions
FVL/CELER/ITA2020
Internal Creative Agency of University of Veterinary and Pharmaceutical Sciences Brno
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2004
Europe PubMed Central
od 2004
ProQuest Central
od 2004-01-01
Open Access Digital Library
od 2004-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2004
PubMed
35745634
DOI
10.3390/ph15060715
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Pattern 1-hydroxy-N-(2,4,5-trichlorophenyl)-2-naphthamide and the thirteen original carbamates derived from it were prepared and characterized. All the compounds were tested against Staphylococcus aureus ATCC 29213 as a reference and quality control strain and in addition against three clinical isolates of methicillin-resistant S. aureus (MRSA). Moreover, the compounds were evaluated against Enterococcus faecalis ATCC 29212, and preliminary in vitro cytotoxicity of the compounds was assessed using the human monocytic leukemia cell line (THP-1). The lipophilicity of the prepared compounds was experimentally determined and correlated with biological activity. While pattern anilide had no antibacterial activity, the prepared carbamates demonstrated high antistaphylococcal activity comparable to the used standards (ampicillin and ciprofloxacin), which unfortunately were ineffective against E. feacalis. 2-[(2,4,5-Trichlorophenyl)carba- moyl]naphthalen-1-yl ethylcarbamate (2) and 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl butylcarbamate (4) expressed the nanomolar minimum inhibitory concentrations (MICs 0.018-0.064 μM) against S. aureus and at least two other MRSA isolates. Microbicidal effects based on the minimum bactericidal concentrations (MBCs) against all the tested staphylococci were found for nine carbamates, while 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl heptylcarbamate (7) and 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl (4-phenylbutyl)carbamate (14) demonstrated MBCs in the range of 0.124-0.461 μM. The selectivity index (SI) for most investigated carbamates was >20 and for some derivatives even >100. The performed tests did not show an effect on the damage to the bacterial membrane, while the compounds were able to inhibit the respiratory chain of S. aureus.
Global Change Research Institute CAS Belidla 986 4a 60300 Brno Czech Republic
Institute of Chemistry University of Silesia Bankowa 12 40007 Katowice Poland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017019
- 003
- CZ-PrNML
- 005
- 20220720100055.0
- 007
- ta
- 008
- 220718s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ph15060715 $2 doi
- 035 __
- $a (PubMed)35745634
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Gonec, Tomas $u Department of Chemical Drugs, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 61200 Brno, Czech Republic $1 https://orcid.org/0000000337128641 $7 xx0107280
- 245 10
- $a Antistaphylococcal Activities and ADME-Related Properties of Chlorinated Arylcarbamoylnaphthalenylcarbamates / $c T. Gonec, D. Pindjakova, L. Vrablova, T. Strharsky, H. Michnova, T. Kauerova, P. Kollar, M. Oravec, I. Jendrzejewska, A. Cizek, J. Jampilek
- 520 9_
- $a Pattern 1-hydroxy-N-(2,4,5-trichlorophenyl)-2-naphthamide and the thirteen original carbamates derived from it were prepared and characterized. All the compounds were tested against Staphylococcus aureus ATCC 29213 as a reference and quality control strain and in addition against three clinical isolates of methicillin-resistant S. aureus (MRSA). Moreover, the compounds were evaluated against Enterococcus faecalis ATCC 29212, and preliminary in vitro cytotoxicity of the compounds was assessed using the human monocytic leukemia cell line (THP-1). The lipophilicity of the prepared compounds was experimentally determined and correlated with biological activity. While pattern anilide had no antibacterial activity, the prepared carbamates demonstrated high antistaphylococcal activity comparable to the used standards (ampicillin and ciprofloxacin), which unfortunately were ineffective against E. feacalis. 2-[(2,4,5-Trichlorophenyl)carba- moyl]naphthalen-1-yl ethylcarbamate (2) and 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl butylcarbamate (4) expressed the nanomolar minimum inhibitory concentrations (MICs 0.018-0.064 μM) against S. aureus and at least two other MRSA isolates. Microbicidal effects based on the minimum bactericidal concentrations (MBCs) against all the tested staphylococci were found for nine carbamates, while 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl heptylcarbamate (7) and 2-[(2,4,5-trichlorophenyl)carbamoyl]naphthalen-1-yl (4-phenylbutyl)carbamate (14) demonstrated MBCs in the range of 0.124-0.461 μM. The selectivity index (SI) for most investigated carbamates was >20 and for some derivatives even >100. The performed tests did not show an effect on the damage to the bacterial membrane, while the compounds were able to inhibit the respiratory chain of S. aureus.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pindjakova, Dominika $u Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 84215 Bratislava, Slovakia
- 700 1_
- $a Vrablova, Lucia $u Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 84215 Bratislava, Slovakia
- 700 1_
- $a Strharsky, Tomas $u Department of Chemical Drugs, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 61200 Brno, Czech Republic $1 https://orcid.org/0000000192915424
- 700 1_
- $a Michnova, Hana $u Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackeho 1946/1, 61242 Brno, Czech Republic
- 700 1_
- $a Kauerova, Tereza $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 61200 Brno, Czech Republic $1 https://orcid.org/000000032854511X
- 700 1_
- $a Kollar, Peter $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Palackeho 1946/1, 61200 Brno, Czech Republic $1 https://orcid.org/0000000322651528
- 700 1_
- $a Oravec, Michal $u Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic $1 https://orcid.org/0000000225065826
- 700 1_
- $a Jendrzejewska, Izabela $u Institute of Chemistry, University of Silesia, Bankowa 12, 40007 Katowice, Poland $1 https://orcid.org/0000000260255772
- 700 1_
- $a Cizek, Alois $u Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackeho 1946/1, 61242 Brno, Czech Republic $1 https://orcid.org/0000000157064601
- 700 1_
- $a Jampilek, Josef $u Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 84215 Bratislava, Slovakia $u Department of Chemical Biology, Faculty of Science, Palacky University Olomouc, Slechtitelu 27, 78371 Olomouc, Czech Republic $1 https://orcid.org/0000000320039052 $7 xx0027075
- 773 0_
- $w MED00184066 $t Pharmaceuticals (Basel, Switzerland) $x 1424-8247 $g Roč. 15, č. 6 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35745634 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100050 $b ABA008
- 999 __
- $a ind $b bmc $g 1816411 $s 1168261
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 15 $c 6 $e 20220605 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
- GRA __
- $a APVV-17-0373 $p Slovak Research and Development Agency
- GRA __
- $a UK/289/2022 $p Comenius University
- GRA __
- $a UK/320/2022 $p Comenius University
- GRA __
- $a LM2018123 $p Large Research Infrastructure CzeCOS
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000797 $p SustES-Adaptation strategies for sustainable ecosystem services and food security under ad-verse environmental conditions
- GRA __
- $a FVL/CELER/ITA2020 $p Internal Creative Agency of University of Veterinary and Pharmaceutical Sciences Brno
- LZP __
- $a Pubmed-20220718